US4758524A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Monoclonal antibodies with specificity for crosslinked fibrin derivatives and assay for said derivatives
Assignee: Fielder Gillespie David Ltd
•
Filing: 1984-03-15
•
Granted: 1988-07-19
•
Expires: 2004-03-15
Abstract
Abstract The invention relates to a method of a preparation of monoclonal antibody derived from a crosslinked fibrin derivative including the steps of: (i) obtaining a crosslinked fibrin derivative or extract containing same; and (ii) forming an antibody to said derivative or extract by cloning antibody producing cells from an animal having been administered thereto said derivative or extract. A screening assay for use in the abovementioned method which includes the steps of: (A) coating a surface with an antigen selected from a (i) crosslinked fibrin derivative; (ii) extract containing said derivative; or (iii) fibrinogen degradation product. (B) contacting said antigen with a monoclonal antibody derived from crosslinked fibrin derivative; and (C) subjecting the complex formed in step (A) to a signal amplification step and an assay procedure for detection of the presence of a crosslinked fibrin derivative in an animal body fluid including the steps of: (i) contacting a monoclonal antibody prepared from a crosslinked fibrin derivative with a fluid sample suspected of containing an antigen derived from a crosslinked fibrin derivative or comprising a crosslinked fibrin derivative per se; and (ii) subjecting the complex formed in step (i) to a signal amplification step are also provided.
Inventors
- 👤 Peter G. Bundesen
- 👤 Dennis B. Rylatt
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 10:18
CPC Classifications
C; C12; C12P; C12P21/00; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/86; A; A61; A61K; A61K39/00; A61K39/395; C07; C07K; C07K16/00; C07K16/18; G01N2333/00; G01N2333/435; G01N2333/745; G01N2333/75
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
68 words
A screening assay for determining whether cells are producing antibody specific to a cross-linked fibrin derivative including the steps of: (A) coating a surface with antigen selected from (i) cross-linked fibrin derivative; (ii) extract containing said derivative; or (iii) fibrinogen degradation product; (B) contacting said antigen with monoclonal antibody reactive only with cross-linked fibrin derivative to form a complex; and (C) detecting said complex formed in step (B).
Claim 2
Dependent Claim
68 words
A screening assay for determining whether cells are producing antibody specific to a cross-linked fibrin derivative including the steps of: (A) coating a surface with antigen selected from (i) cross-linked fibrin derivative; (ii) extract containing said derivative; or (iii) fibrinogen degradation product; (B) contacting said antigen with monoclonal antibody reactive only with cross-linked fibrin derivative to form a complex; and (C) detecting said complex formed in step (B).
Claim 3
Dependent Claim
29 words
An assay as claimed in claim 1 wherein in step (A) a well plate is utilized in which antigen is added to each well prior to said monoclonal antibody.
Claim 4
Dependent Claim
65 words
An assay procedure for detection of the presence of a crosslinked fibrin derivative in a fluid including the steps of: (i) contacting monoclonal antibody reactive only with crosslinked fibrin derivative, with a fluid sample suspected of containing an antigen derived from a crosslinked fibrin derivative or a crosslinked fibrin derivative per se, to form a complex; and (ii) detecting said complex formed in step (i).
Claim 5
Dependent Claim
65 words
An assay procedure for detection of the presence of a crosslinked fibrin derivative in a fluid including the steps of: (i) contacting monoclonal antibody reactive only with crosslinked fibrin derivative, with a fluid sample suspected of containing an antigen derived from a crosslinked fibrin derivative or a crosslinked fibrin derivative per se, to form a complex; and (ii) detecting said complex formed in step (i).
Claim 6
Dependent Claim
16 words
An assay procedure as claimed in claim 3 wherein the crosslinked fibrin derivative is D dimer.
Claim 7
Dependent Claim
40 words
An assay procedure as claimed in claim 3 wherein a first monoclonal antibody in step (i) is bound or captured to an antigen in said body fluid which is subsequently tagged in step (ii) by a labelled second monoclonal antibody.
Claim 8
Dependent Claim
23 words
An assay procedure as claimed in claim 5 wherein said first monoclonal antibody is monospecific and said second monoclonal antibody is pan specific.
Claim 9
Dependent Claim
22 words
An assay procedure as claimed in claim 5 wherein said first monoclonal antibody is monospecific and said second monoclonal antibody is monospecific.
Claim 10
Dependent Claim
23 words
An assay procedure as claimed in claim 5 wherein said first monoclonal antibody is pan specific and said second monoclonal antibody is monospecific.
Claim 11
Dependent Claim
28 words
An assay procedure as claimed in claim 5 wherein the second monoclonal antibody is labelled with an enzyme which is subsequently reacted with a substrate for said enzyme.
Claim 12
Dependent Claim
19 words
An assay procedure as claimed in claim 5 wherein the second monoclonal antibody is labelled with a radioactive species.
Claim 13
Dependent Claim
35 words
An assay procedure in claim 3 wherein the monoclonal antibody in step (i) is initially coupled to latex beads before being contacted with said fluid sample and subsequently being checked for agglutination in step (ii).
Claim 14
Independent Claim
159 words
A method of detection of crosslinked fibrin derivative in a body fluid including the steps of: (i) immunizing an animal with a crosslinked fibrin derivative or extract containing same; (ii) removing a spleen from the animal; (iii) treating the spleen to form a cell suspension; (iv) purifying the cell suspension to isolate spleen white blood cells or lymphocytes. (v) forming hybridoma cells containing as one component said spleen white blood cells or lymphocytes; (iv) cloning or recloning said hybridoma cells using appropriate cell feeder layers; (vii) carrying out screening assays with antigen selected from crosslinked fibrin derivative or extract containing same or fibrinogen degredation product so as to isolate hybridoma cells which produce monoclonal antibody reactive only with cross-linked fibrin derivative; (viii) contacting a fluid sample suspected of containing crosslinked fibrin derivative or antigen derived therefrom with monoclonal antibody prepared from hybridoma cells isolated after step (vii) to form a complex, and detecting said complex formed in step (viii).
Claim 15
Independent Claim
159 words
A method of detection of crosslinked fibrin derivative in a body fluid including the steps of: (i) immunizing an animal with a crosslinked fibrin derivative or extract containing same; (ii) removing a spleen from the animal; (iii) treating the spleen to form a cell suspension; (iv) purifying the cell suspension to isolate spleen white blood cells or lymphocytes. (v) forming hybridoma cells containing as one component said spleen white blood cells or lymphocytes; (iv) cloning or recloning said hybridoma cells using appropriate cell feeder layers; (vii) carrying out screening assays with antigen selected from crosslinked fibrin derivative or extract containing same or fibrinogen degredation product so as to isolate hybridoma cells which produce monoclonal antibody reactive only with cross-linked fibrin derivative; (viii) contacting a fluid sample suspected of containing crosslinked fibrin derivative or antigen derived therefrom with monoclonal antibody prepared from hybridoma cells isolated after step (vii) to form a complex, and detecting said complex formed in step (viii).
Claim 16
Independent Claim
83 words
A method of diagnosis of disseminated intravascular coagulation (DIC) and other thrombotic states including the steps of: (i) isolating a monoclonal antibody reacting with crosslinked fibrin derivative but not fragment D, fragment E, fibrinogen or fibrinogen degradation products; (ii) contacting said monoclonal antibody with a fluid sample from a patient suspected of suffering from DIC or other thrombotic state; and, (iii) analyzing for presence of cross-linked fibrin derivative in said sample to determine if the cross-linked fibrin derivative reacted with said monoclonal antibody.
Claim 17
Independent Claim
83 words
A method of diagnosis of disseminated intravascular coagulation (DIC) and other thrombotic states including the steps of: (i) isolating a monoclonal antibody reacting with crosslinked fibrin derivative but not fragment D, fragment E, fibrinogen or fibrinogen degradation products; (ii) contacting said monoclonal antibody with a fluid sample from a patient suspected of suffering from DIC or other thrombotic state; and, (iii) analyzing for presence of cross-linked fibrin derivative in said sample to determine if the cross-linked fibrin derivative reacted with said monoclonal antibody.
Claim 18
Independent Claim
73 words
A method of diagnosis of disseminated intravascular coagulation (DIC) and other thrombotic states including the steps of: (i) isolating a monoclonal antibody reacting only with crosslinked fibrin derivative; (ii) contacting said monoclonal antibody with a fluid sample from a patient suspected of suffering from DIC or other thrombotic state; and, (iii) analyzing for presence of cross-linked fibrin derivative in said sample to determine if the cross-linked fibrin derivative reacted with said monoclonal antibody.
Claim 19
Independent Claim
73 words
A method of diagnosis of disseminated intravascular coagulation (DIC) and other thrombotic states including the steps of: (i) isolating a monoclonal antibody reacting only with crosslinked fibrin derivative; (ii) contacting said monoclonal antibody with a fluid sample from a patient suspected of suffering from DIC or other thrombotic state; and, (iii) analyzing for presence of cross-linked fibrin derivative in said sample to determine if the cross-linked fibrin derivative reacted with said monoclonal antibody.
Claim 20
Dependent Claim
13 words
A method as in claim 13 wherein said crosslinked fibrin derivative is D-dimer.
References Cited (Backward Citations)
US4196265A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-07-19 | 1992-01-18 | 1992-07-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-07-19 | 1996-01-18 | 1996-07-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-07-19 | 2000-01-18 | 2000-07-19 | $7700.00 | Window Closed / Lapsed |